Zumiez (ZUMZ) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
20 Oct, 2025Executive summary
Second quarter net sales rose 1.9% year-over-year to $214.3 million, with comparable sales up 2.5% and North America driving performance.
North American comparable sales outperformed, increasing 4.2% in Q2 and 13.0% in the first 30 days of Q3, while international markets faced challenges.
Net loss for Q2 was $1.0 million ($0.06 per share), compared to a $0.8 million loss last year.
Six-month net sales increased 2.9% to $398.6 million, with a net loss of $15.3 million ($0.88 per share), improved from a $17.6 million loss last year.
Strategic focus remains on revenue growth, profitability optimization, and leveraging a strong financial foundation.
Financial highlights
Q2 net sales were $214.3 million, up 1.9% year-over-year; North America net sales rose 2.1%, while international net sales increased 1%.
Gross profit was $76 million (35.5% of sales), up 5.9% year-over-year; gross margin improved by 130 basis points.
Operating income for Q2 was $0.1 million (0.1% of sales), compared to a $0.4 million loss last year.
SG&A expense was $75.9 million (35.4% of sales), up 5.2% year-over-year and flat as a percent of sales.
Cash and marketable securities at quarter-end were $106.7 million, with no debt.
Outlook and guidance
Q3 net sales expected between $232 million and $237 million, with comparable sales growth of 5.5%–7.5%.
Q3 product margin and operating income (2.3%–3.3% of sales) expected to improve; EPS guidance of $0.19–$0.29.
Full-year 2025 sales growth projected at 3%–4%, with modest product margin gains and flat SG&A as a percent of sales (excluding one-time legal charges).
Six new stores planned for 2025, 20 closures; capex expected at $11–$13 million.
Management expects liquidity from operations and cash reserves to be sufficient for at least the next 12 months.
Latest events from Zumiez
- Strong Q4 and FY25 results with margin gains and a new $40M buyback authorized.ZUMZ
Q4 202612 Mar 2026 - Gross margin rose to 29.3% as net loss narrowed and a $25M buyback was authorized.ZUMZ
Q1 20251 Feb 2026 - Q2 net sales rose 8.1%, gross margin expanded, and net loss narrowed on strong comps.ZUMZ
Q2 202522 Jan 2026 - Q3 net sales up 2.9%, comp sales up 7.5%, and margins improved; Q4 outlook remains strong.ZUMZ
Q3 202511 Jan 2026 - Q3 sales and EPS surged, with strong North America growth and positive Q4 outlook.ZUMZ
Q3 20267 Dec 2025 - Q4 profit more than doubled on higher margins; 2025 outlook cautious amid volatility.ZUMZ
Q4 20252 Dec 2025 - Proxy covers director elections, executive pay, auditor ratification, and ESG priorities.ZUMZ
Proxy Filing1 Dec 2025 - Director elections, say-on-pay, and auditor ratification headline the June 2025 meeting.ZUMZ
Proxy Filing1 Dec 2025 - Q1 sales rose 3.9% with margin gains, narrowed loss, and new buybacks amid tariff risks.ZUMZ
Q1 202613 Nov 2025